The Doge's Ball
How Venice Rigged a Global Financial Collapse
https://archive.schillerinstitute.com/fid_91-96/954_Gallagher_Venice_rig.html
The correct treatment for severe COVID-19 related sepsisis non-invasive ventilation, steroids, and
antioxidant infusions. Most of the drugs repurposed for COVID-19 that show any beneft
whatsoever in rescuing critically-ill COVID-19 patients are antioxidants.
N-acetylcysteine, melatonin, fuvoxamine, budesonide, famotidine, cimetidine, and ranitidine are all antioxidants.
Indomethacin prevents iron- driven oxidation of arachidonic acid to isoprostanes. There are
powerful antioxidants such as apocynin that have not even been tested on COVID-19 patients yet
which could defang neutrophils, prevent lipid peroxidation, restore endothelial health, and restore
oxygenation to the tissues.
Scientists who know anything about pulmonary neutrophilia, ARDS, and redox biology have known
or surmised much of this since March 2020. In April 2020, Swiss scientists confrmed that COVID-
19 was a vascular endotheliitis. By late 2020, experts had already concluded that COVID-19
causes a form of viral sepsis. They also know that sepsis can be efectively treated with
antioxidants. None of this information is particularly new, and yet, for the most part, it has not been
acted upon. Doctors continue to use damaging intubation techniques with high PEEP settings
despite high lung compliance and poor oxygenation, killing an untold number of critically ill patients
with medical malpractice.
Because of the way they are constructed, Randomized Control Trials will never show any beneft
for any antiviral against COVID-19. Not Remdesivir, not Kaletra, not HCQ, and not Ivermectin. The
reason for this is simple; for the patients that they have recruited for these studies, such as
Oxford’s ludicrous RECOVERY study, the intervention is too late to have any positive efect.
The clinical course of COVID-19 is such that by the time most people seek medical attention for
hypoxia, their viral load has already tapered of to almost nothing. If someone is about 10 days
post-exposure and has already been symptomatic for fve days, there is hardly any virus left in their
bodies, only cellular damage and derangement that has initiated a hyperinfammatory response. It
is from this group that the clinical trials for antivirals have recruited, pretty much exclusively.
In these trials, they give antivirals to severely ill patients who have no virus in their bodies, only a
delayed hyperinfammatory response, and then absurdly claim that antivirals have no utility in
treating or preventing COVID-19. These clinical trials do not recruit people who are presymptomatic.
They do not test pre-exposure or post-exposure prophylaxis.
The correct treatment for severe COVID-19 related sepsisis non-invasive ventilation, steroids, and
antioxidant infusions. Most of the drugs repurposed for COVID-19 that show any beneft
whatsoever in rescuing critically-ill COVID-19 patients are antioxidants.
N-acetylcysteine, melatonin, fuvoxamine, budesonide, famotidine, cimetidine, and ranitidine are all antioxidants.
Indomethacin prevents iron- driven oxidation of arachidonic acid to isoprostanes. There are
powerful antioxidants such as apocynin that have not even been tested on COVID-19 patients yet
which could defang neutrophils, prevent lipid peroxidation, restore endothelial health, and restore
oxygenation to the tissues.
Scientists who know anything about pulmonary neutrophilia, ARDS, and redox biology have known
or surmised much of this since March 2020. In April 2020, Swiss scientists confrmed that COVID-
19 was a vascular endotheliitis. By late 2020, experts had already concluded that COVID-19
causes a form of viral sepsis. They also know that sepsis can be efectively treated with
antioxidants. None of this information is particularly new, and yet, for the most part, it has not been
acted upon. Doctors continue to use damaging intubation techniques with high PEEP settings
despite high lung compliance and poor oxygenation, killing an untold number of critically ill patients
with medical malpractice.
Because of the way they are constructed, Randomized Control Trials will never show any beneft
for any antiviral against COVID-19. Not Remdesivir, not Kaletra, not HCQ, and not Ivermectin. The
reason for this is simple; for the patients that they have recruited for these studies, such as
Oxford’s ludicrous RECOVERY study, the intervention is too late to have any positive efect.
The clinical course of COVID-19 is such that by the time most people seek medical attention for
hypoxia, their viral load has already tapered of to almost nothing. If someone is about 10 days
post-exposure and has already been symptomatic for fve days, there is hardly any virus left in their
bodies, only cellular damage and derangement that has initiated a hyperinfammatory response. It
is from this group that the clinical trials for antivirals have recruited, pretty much exclusively.
In these trials, they give antivirals to severely ill patients who have no virus in their bodies, only a
delayed hyperinfammatory response, and then absurdly claim that antivirals have no utility in
treating or preventing COVID-19. These clinical trials do not recruit people who are presymptomatic.
They do not test pre-exposure or post-exposure prophylaxis.
The correct treatment for severe COVID-19 related sepsisis non-invasive ventilation, steroids, and
antioxidant infusions. Most of the drugs repurposed for COVID-19 that show any beneft
whatsoever in rescuing critically-ill COVID-19 patients are antioxidants.
N-acetylcysteine, melatonin, fuvoxamine, budesonide, famotidine, cimetidine, and ranitidine are all antioxidants.
Indomethacin prevents iron- driven oxidation of arachidonic acid to isoprostanes. There are
powerful antioxidants such as apocynin that have not even been tested on COVID-19 patients yet
which could defang neutrophils, prevent lipid peroxidation, restore endothelial health, and restore
oxygenation to the tissues.
Scientists who know anything about pulmonary neutrophilia, ARDS, and redox biology have known
or surmised much of this since March 2020. In April 2020, Swiss scientists confrmed that COVID-
19 was a vascular endotheliitis. By late 2020, experts had already concluded that COVID-19
causes a form of viral sepsis. They also know that sepsis can be efectively treated with
antioxidants. None of this information is particularly new, and yet, for the most part, it has not been
acted upon. Doctors continue to use damaging intubation techniques with high PEEP settings
despite high lung compliance and poor oxygenation, killing an untold number of critically ill patients
with medical malpractice.
Because of the way they are constructed, Randomized Control Trials will never show any beneft
for any antiviral against COVID-19. Not Remdesivir, not Kaletra, not HCQ, and not Ivermectin. The
reason for this is simple; for the patients that they have recruited for these studies, such as
Oxford’s ludicrous RECOVERY study, the intervention is too late to have any positive efect.
The clinical course of COVID-19 is such that by the time most people seek medical attention for
hypoxia, their viral load has already tapered of to almost nothing. If someone is about 10 days
post-exposure and has already been symptomatic for fve days, there is hardly any virus left in their
bodies, only cellular damage and derangement that has initiated a hyperinfammatory response. It
is from this group that the clinical trials for antivirals have recruited, pretty much exclusively.
In these trials, they give antivirals to severely ill patients who have no virus in their bodies, only a
delayed hyperinfammatory response, and then absurdly claim that antivirals have no utility in
treating or preventing COVID-19. These clinical trials do not recruit people who are presymptomatic.
They do not test pre-exposure or post-exposure prophylaxis.
It looks like Fauci has been torturing dogs.
What kind of monster tortures humanity's most innocent companions?